Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) EBIT (2020 - 2025)

Historic EBIT for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • IceCure Medical's EBIT fell 1064.52% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 560.13%. This contributed to the annual value of $15.7 million for FY2024, which is 77.04% up from last year.
  • According to the latest figures from Q3 2025, IceCure Medical's EBIT is $3.8 million, which was down 1064.52% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's EBIT ranged from a high of $4.5 million in Q4 2024 and a low of -$29.5 million during Q4 2022
  • Over the past 5 years, IceCure Medical's median EBIT value was $3.7 million (recorded in 2025), while the average stood at $825631.6.
  • Per our database at Business Quant, IceCure Medical's EBIT tumbled by 12976.21% in 2021 and then surged by 27091.37% in 2022.
  • Over the past 5 years, IceCure Medical's EBIT (Quarter) stood at -$16.3 million in 2021, then crashed by 81.04% to -$29.5 million in 2022, then skyrocketed by 111.56% to $3.4 million in 2023, then skyrocketed by 32.5% to $4.5 million in 2024, then fell by 15.23% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $3.4 million for Q2 2025, and $3.7 million during Q1 2025.